Guggenheim Capital’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,343
Closed -$212K 1998
2022
Q4
$212K Buy
+9,343
New +$211K ﹤0.01% 1788
2021
Q3
Sell
-5,419
Closed -$211K 2215
2021
Q2
$211K Sell
5,419
-547
-9% -$19.6K ﹤0.01% 2124
2021
Q1
$204K Sell
5,966
-5,610
-48% -$239K ﹤0.01% 2087
2020
Q4
$525K Buy
+11,576
New +$404K ﹤0.01% 1616
2019
Q4
Sell
-43,125
Closed -$1.53M 2151
2019
Q3
$1.53M Buy
43,125
+1,680
+4% +$68.1K 0.01% 1117
2019
Q2
$2.13M Sell
41,445
-3,150
-7% -$157K 0.02% 1032
2019
Q1
$2.56M Buy
44,595
+2,139
+5% +$106K 0.02% 965
2018
Q4
$1.78M Buy
+42,456
New +$2.49M 0.02% 1102

Other funds holding RGNX